Management of Elderly Female with High Blood Sugar

Immediate Medication Adjustments

The American Diabetes Association recommends increasing metformin from 500mg daily to 1000mg daily (500mg twice daily with meals) and adding basal insulin while checking fingerstick blood glucose 4 times daily until glycemic control stabilizes 1
Before any dose increase, verify eGFR is ≥45 mL/min/1.73m²—metformin initiation is not recommended if eGFR is 30-45, and contraindicated if <30 1
With an A1C of 14.2%, metformin monotherapy will be insufficient—add basal insulin (NPH, glargine, or detemir) starting at 10 units in the morning 1
Titrate basal insulin by 2 units every week based on fasting fingerstick glucose values, targeting 90-150 mg/dL (may adjust to 100-180 mg/dL given her age and to minimize hypoglycemia risk) 1
If eGFR >45 mL/min/1.73m², consider adding a GLP-1 receptor agonist or SGLT2 inhibitor as second-line agents after metformin optimization, particularly if cardiovascular or renal comorbidities exist 1

Check fingerstick blood glucose 4 times daily: fasting, before lunch, before dinner, and at bedtime 1
Continue this frequency for at least 2-4 weeks or until glucose patterns stabilize and A1C approaches target 1
Once glucose values are consistently in target range (90-150 mg/dL premeal), reduce to checking fasting glucose daily plus one additional premeal value rotating through the day 1
Every 2 weeks, assess glucose patterns and adjust insulin dose or add/adjust glucose-lowering agents based on premeal values 1

Target A1C of 7.5-8% is appropriate for most elderly patients with diabetes, balancing microvascular risk reduction against hypoglycemia risk 1, 4, 5
Fasting and premeal glucose: 90-150 mg/dL (may liberalize to 100-180 mg/dL if hypoglycemia risk is high) 1
Avoid glucose values consistently <90 mg/dL to prevent hypoglycemia 1
Also avoid symptomatic hyperglycemia (generally >250-300 mg/dL) 1

Older adults are at substantially higher risk of hypoglycemia, which can cause falls, fractures, cognitive decline, and cardiovascular events 1, 4, 5
Educate patient and caregivers on hypoglycemia recognition (confusion, shakiness, sweating) and treatment (15g fast-acting carbohydrate) 2
Assess cognitive and functional status—if impaired, simplify the regimen and set less stringent targets 1, 4
Temporarily discontinue metformin before procedures with iodinated contrast (if eGFR 30-60), during hospitalizations, or if acute illness compromises renal/hepatic function 1

Do not delay insulin initiation—with A1C 14.2%, oral agents alone will not achieve control in a reasonable timeframe 1
Do not use sliding-scale insulin alone—basal insulin with scheduled dosing is far more effective 1
Do not set overly aggressive targets (A1C <7%) if the patient has limited life expectancy, multiple comorbidities, or high hypoglycemia risk 1, 4, 5, 3